ViaValve Safety IV Catheter Receives Clearance from the FDA
Smiths Medical announces that its ViaValve Safety I.V. Catheter has been cleared by the Food and Drug Administration (FDA) and can be marketed in the United States. The ViaValve catheter is designed to enhance clinician and patient safety by helping reduce the risk of both blood exposure and needlestick injury and will be available for sale by the end of summer 2012.
The ViaValve Safety I.V. Catheter can help reduce the risk of blood exposure by means of an integrated valve in the catheter hub. The valve provides blood control by impeding the backflow of blood from the patients vein upon initial venipuncture. This helps to prevent the transfer of bloodborne pathogens from patient to caregiver on soiled gloves, clothing, bedding and dressings by maintaining a clean access site. ViaValve Safety I.V. Catheter also helps prevent inadvertent needlesticks, which, each year, affect approximately 800,000 hospital-based healthcare workers in the U.S.
For nearly 20 years, Smiths Medicals Jelco® safety I.V. catheters have provided needlestick protection consistent with legislation driven by the U.S. Needlestick Safety and Prevention ACT and OSHAs bloodborne pathogens standards (29 CFR 1910.1030). FDA 510(k) clearance of ViaValve Safety I.V. Catheter will allow the company to market a catheter that could help advance I.V. catheter safety by establishing an even higher standard of safety with requirements for blood control.
We are pleased to add a solution that helps to reduce bloodborne infections during I.V. starts, says Tommy Johns, vice president of global product management. The ViaValve Safety I.V. Catheter is the latest advancement in I.V. safety, and is built on the proven Jelco® catheter platform that has been a favorite of clinicians for almost two decades. It is our objective to produce innovative medical products with the purpose of promoting patient, clinician and healthcare worker safety while supporting the best possible clinical outcome.
Product(s) described may not be licensed or available for sale in all countries. The ViaValve catheter is FDA 510(k) cleared in the U.S.
Â
From Shortages to Security: How Reusable Health Care Textiles Can Transform Infection Prevention
March 7th 2025Reusable health care textiles enhance infection prevention, reduce waste, and strengthen supply chains. Hygienically clean textiles offer a sustainable, cost-effective alternative to disposable PPE, ensuring patient safety and environmental responsibility.
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.
